Deciphera Pharmaceuticals Net Income

Deciphera Pharmaceuticals (DCPH) currently reports a net income of $-190M as of March 2024. That compares with $-180M in the prior-year period — down 4.8% year over year. That is below the Healthcare sector average of $16B. Use the charts on this page to explore Deciphera Pharmaceuticals's net income history and peer comparisons.

Deciphera Pharmaceuticals's net income decreased from $-180M to $-190M — a 4.8% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deciphera Pharmaceuticals's net income of $-190M is lower than the Healthcare sector average of $16B. That is roughly 101.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Deciphera Pharmaceuticals reported $-190M in net income as of March 2024. That compares with $-180M in the prior-year period — down 4.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-190M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $16B. From there, open related valuation or income-statement pages for Deciphera Pharmaceuticals, and consider following DCPH for alerts when major investors trade the stock.